Time to tackle clonorchiasis in China

Infectious Diseases of Poverty

Volumn 2, Issue 1, 2013, Pages

  Qian, Men Bao ^a   Chen, Ying Dan ^a   Yan, Fei ^b  

^a BEIJING HOSPITAL   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Clonorchiasis; Clonorchis sinensis; Hepatitis B virus; Liver cancer; Research

Indexed keywords

PRAZIQUANTEL;

ARTICLE; BILE DUCT CARCINOMA; CARCINOGENICITY; CHINA; CLINICAL FEATURE; CLONORCHIASIS; CLONORCHIS SINENSIS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; META ANALYSIS (TOPIC); NONHUMAN; OPISTHORCHIASIS; OPISTHORCHIS VIVERRINI; PRIORITY JOURNAL; PUBLIC HEALTH;

EID: 84878446494     PISSN: None     EISSN: 20499957     Source Type: Journal    
DOI: 10.1186/2049-9957-2-4     Document Type: Article

References (31)

1. Qian MB, Chen YD, Liang S, Yang GJ, Zhou XN. The global epidemiology of clonorchiasis and its relation with cholangiocarcinoma. Infectious Diseases of Poverty 2012, 1:4.
2. First WHO report on neglected tropical diseases 2010: working to overcome the global impact of neglected tropical diseases Available: http://www.who.int/neglected_diseases/2010report/en/ Accessed 27 October 2010.
3. Lu FM, Zhuang H. Management of hepatitis B in China. Chin Med J (Engl) 2009, 122:3-4.
4. World Health Organization Hepatitis B vaccines. Wkly Epidemiol Rec 2009, 84:405-419. World Health Organization.
5. WHO Control of Foodborne Trematode Infections 1995, Geneva: World Health Organization, WHO technical Report Series, WHO.
6. Sithithaworn P, Andrews RH, Nguyen VD, Wongsaroj T, Sinuon M, Odermatt P, Nawa Y, Liang S, Brindley PJ, Sripa B. The current status of opisthorchiasis and clonorchiasis in the Mekong Basin. Parasitol Int 2012, 61:10-16. 10.1016/j.parint.2011.08.014, 21893213.
7. Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, Wang F, Zheng H, Wang F, Guo J, Jia Z, Ma J, Wang H, Luo H, Li L, Jin S, Hadler SC, Wang Y. Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine 2009, 27:6550-6557. 10.1016/j.vaccine.2009.08.048, 19729084.
8. Keiser J, Utzinger J. Food-borne trematodiases. Clin Microbiol Rev 2009, 22:466-483. 10.1128/CMR.00012-09, 2708390, 19597009.
9. Wilkins T, Zimmerman D, Schade RR. Hepatitis B: diagnosis and treatment. Am Fam Physician 2010, 81:965-972.
10. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V. WHO International Agency for Research on Cancer Monograph Working Group A review of human carcinogens-Part B: biological agents. Lancet Oncol 2009, 10:321-322. 10.1016/S1470-2045(09)70096-8, 19350698, WHO International Agency for Research on Cancer Monograph Working Group.
11. International Agency for Research on Cancer A Review of Human Carcinogens Part B: Biological Agents. IARC monographs on the evaluation of carcinogenic risks to humans 2011, Lyon: IARC, International Agency for Research on Cancer.
12. Srivatanakul P, Sriplung H, Deerasamee S. Epidemiology of liver cancer: an overview. Asian Pac J Cancer Prev 2004, 5:118-125.
13. Shi J, Zhu L, Liu S, Xie WF. A meta-analysis of case-control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China. Br J Cancer 2005, 92:607-612. 2362087, 15685242.
14. Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, Huang GT, Iloeje UH. REVEAL-HBV Study Group Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006, 295:65-73. 10.1001/jama.295.1.65, 16391218, REVEAL-HBV Study Group.
15. Haswell-Elkins MR, Mairiang E, Mairiang P, Chaiyakum J, Chamadol N, Loapaiboon V, Sithithaworn P, Elkins DB. Cross-sectional study of Opisthorchis viverrini infection and cholangiocarcinoma in communities within a high-risk area in northeast Thailand. Int J Cancer 1994, 59:505-509. 10.1002/ijc.2910590412, 7960220.
16. Qian MB, Chen YD, Fang YY, Xu LQ, Zhu TJ, Tan T, Zhou CH, Wang GF, Jia TW, Yang GJ, Zhou XN. Disability weight of Clonorchis sinensis infection: captured from community study and model simulation. PLoS Negl Trop Dis 2011, 5:e1377. 10.1371/journal.pntd.0001377, 3236727, 22180791.
17. WHO Global burden of disease 2004 update: disability weights for diseases and conditions Available: http://www.who.int/healthinfo/global_burden_disease/GBD2004_DisabilityWeights.pdf Accessed 14 May 2010.
18. Zhou YH, Wu C, Zhuang H. Vaccination against hepatitis B: the Chinese experience. Chin Med J (Engl) 2009, 122:98-102.
19. Huang TR, Yu JH, Li JL, Zhang ZQ, Deng W, Zhang CY, Zhao SF. A cross-sectional study on liver diseases in the rural residents in southern Guangxi, China. Zhonghua Yu Fang Yi Xue Za Zhi 2007, 41:123-126. in Chinese.
20. Utzinger J. A research and development agenda for the control and elimination of human helminthiases. PLoS Negl Trop Dis 2012, 6:e1646. 10.1371/journal.pntd.0001646, 3335882, 22545174.
21. Zhou XN, Lv S, Yang GJ, Kristensen TK, Bergquist NR, Utzinger J, Malone JB. Spatial epidemiology in zoonotic parasitic diseases: insights gained at the 1st International Symposium on Geospatial Health in Lijiang, China, 2007. Parasit Vectors 2009, 2:10. 10.1186/1756-3305-2-10, 2663554, 19193214.
22. Basáñez MG, McCarthy JS, French MD, Yang GJ, Walker M, Gambhir M, Prichard RK, Churcher TS. A research agenda for helminth diseases of humans: modelling for control and elimination. PLoS Negl Trop Dis 2012, 6:e1548. 10.1371/journal.pntd.0001548, 3335861, 22545162.
23. Gazzinelli A, Correa-Oliveira R, Yang GJ, Boatin BA, Kloos H. A research agenda for helminth diseases of humans: social ecology, environmental determinants, and health systems. PLoS Negl Trop Dis 2012, 6:e1603. 10.1371/journal.pntd.0001603, 3335881, 22545168.
24. Molyneux D, Hallaj Z, Keusch GT, McManus DP, Ngowi H, Cleaveland S, Ramos-Jimenez P, Gotuzzo E, Kar K, Sanchez A, Garba A, Carabin H, Bassili A, Chaignat CL, Meslin FX, Abushama HM, Willingham AL, Kioy D. Zoonoses and marginalised infectious diseases of poverty: where do we stand?. Parasit Vectors 2011, 4:106. 10.1186/1756-3305-4-106, 3128850, 21672216.
25. McCarthy JS, Lustigman S, Yang GJ, Barakat RM, García HH, Sripa B, Willingham AL, Prichard RK, Basáñez MG. A research agenda for helminth diseases of humans: diagnostics for control and elimination programmes. PLoS Negl Trop Dis 2012, 6:e1601. 10.1371/journal.pntd.0001601, 3335877, 22545166.
26. Liu GH, Li B, Li JY, Song HQ, Lin RQ, Cai XQ, Zou FC, Yan HK, Yuan ZG, Zhou DH, Zhu XQ. Genetic variation among Clonorchis sinensis isolates from different geographic regions in China revealed by sequence analyses of four mitochondrial genes. J Helminthol 2012, 86:479-484. 10.1017/S0022149X11000757, 22152452.
27. Prichard RK, Basáñez MG, Boatin BA, McCarthy JS, García HH, Yang GJ, Sripa B, Lustigman S. A research agenda for helminth diseases of humans: intervention for control and elimination. PLoS Negl Trop Dis 2012, 6:e1549. 10.1371/journal.pntd.0001549, 3335868, 22545163.
28. Keiser J, Shu-Hua X, Chollet J, Tanner M, Utzinger J. Evaluation of the in vivo activity of tribendimidine against Schistosoma mansoni, Fasciola hepatica, Clonorchis sinensis, and Opisthorchis viverrini. Antimicrob Agents Chemother 2007, 51:1096-1098. 10.1128/AAC.01366-06, 1803157, 17194822.
29. Xiao SH, Xue J, Xu LL, Zheng Q, Qiang HQ, Zhang YN. The in vitro and in vivo effect of tribendimidine and its metabolites against Clonorchis sinensis. Parasitol Res 2009, 105:1497-1507. 10.1007/s00436-009-1579-6, 19655171.
30. Qian MB, Yap P, Yang YC, Liang H, Jiang ZH, Li W, Tan YG, Zhou H, Utzinger J, Zhou XN, Keiser J. Efficacy and Safety of Tribendimidine against Clonorchis sinensis. Clin Infect Dis 2013. in press.
31. Qian MB, Zhou XN, Fang YY, Liang S, Chen YD. Strengthening the research on clonorchiasis in China. Chin J Parasitol Parasit Dis 2011, 29:211-214. in Chinese.